Donald Treacy

Don brings 30 years of experience across the biotech and pharmaceutical industry, with diverse expertise across research, product development and manufacturing, and regulatory affairs. He most recently was the CEO of Magothy Consulting Group, LLC, and previously held the role of Senior Vice President of Development and Manufacturing Operations at MiddleBrook Pharmaceuticals (formerly Advancis Corporation) and Senior Director of Analytical Sciences for Shire Pharmaceuticals. Don is a named inventor on over 30 issued US and international patents in novel drug delivery, solid dosage form development and formulation performance, and has authored numerous research publications and presentations on accelerator mass spectrometry, high performance liquid chromatography and novel drug delivery systems. He holds a PhD in Analytical and Nuclear Chemistry from the University of Maryland and a B.A. in Chemistry from Roanoke College.